Rhythm Biosciences (ASX:RHY) Shares Climb 14%: Here's What Investors Are Watching - Kalkine
Rhythm Biosciences (ASX:RHY) Shares Climb 14%: Here's What Investors Are Watching Kalkine
Latest articles and price-sensitive announcements with AI sentiment classification.
Rhythm Biosciences (ASX:RHY) Shares Climb 14%: Here's What Investors Are Watching Kalkine

ColoSTAT Access Program now has ten participating clinician sites across Australia. ... Read More The post Rhythm Biosciences doubles ColoSTAT cancer test network to 78 centres appeared first on Stockhead.
other announcement

Series of significant milestones achieved in past 12 months as company starts to look overseas for growth. ... Read More The post Pitt Street flags upside as Rhythm delivers on long-held ‘dream’ appeared first on Stockhead.

Rhythm activates collection centres with 4Cyte Pathology for blood-based ColoSTAT colorectal cancer test ... Read More The post Rhythm ramps up ColoSTAT rollout as 4Cyte sites come online appeared first on Stockhead.
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement